Health Canada Approves Venetoclax for CLL Patients With 17P deletion or if No Other Treatment Options are Available NewsResearch Health Canada Approves Venetoclax for CLL Patients With 17P deletion or if No Other Treatment Options are Available
Lymphoma Canada 2016 Research Fellowship Award NewsResearch Lymphoma Canada 2016 Research Fellowship Award
Health Canada Approves ibrutinib for Waldenström’s Macroglobulinemia NewsResearch Health Canada Approves ibrutinib for Waldenström’s Macroglobulinemia
How Gene Mutation Leads to Follicular Lymphoma Research How Gene Mutation Leads to Follicular Lymphoma
Brentuximab vedotin in elderly Hodgkin lymphoma patients Research Brentuximab vedotin in elderly Hodgkin lymphoma patients
Brentuximab Vedotin as Second-Line Therapy before Autologous Transplantation Research Brentuximab Vedotin as Second-Line Therapy before Autologous Transplantation
BC Cancer Agency Researchers Develop Improved Prognostic Test for Follicular Lymphoma Research BC Cancer Agency Researchers Develop Improved Prognostic Test for Follicular Lymphoma